Literature DB >> 3000528

Autoradiographic analysis of mu1, mu2, and delta opioid binding in the central nervous system of C57BL/6BY and CXBK (opioid receptor-deficient) mice.

A S Moskowitz, R R Goodman.   

Abstract

The recent development of in vitro autoradiography techniques has enabled investigators to determine the distribution and relative levels of multiple ligand binding sites in discrete anatomical areas. In this study we used semi-quantitative in vitro autoradiography to compare the levels of binding to central mu1, mu2, and delta opioid sites in two strains of mice, C57BL/6BY and CXBK. The CXBK strain is known to be deficient in whole brain opioid binding sites and to be less sensitive than the C57 strain to the analgesic and locomotor stimulatory effects of opiates and opioids. Delta sites were visualized using [3H](D-Ala2-D-Leu5]-enkephalin (DADL) plus a low concentration of morphine, total mu sites (mu1 and mu2) were visualized using [3H] dihydromorphine (DHM), and mu2 sites were visualized using [3H]DHM plus a low concentration of DADL. Binding to mu1 sites was determined by subtracting mu2 binding from total mu binding. We found that the two strains did not consistently differ in the levels of delta site; in some areas the CXBKs had lower levels but in many areas they had levels equal to or greater than those for the C57s. The CXBK strain, however, either had less or the same amount of mu binding as the C57 strain in all areas studied. The CXBK strain was especially deficient in mu1 binding, particularly in areas involved in pain processing.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3000528     DOI: 10.1016/0006-8993(85)91226-0

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  17 in total

Review 1.  Development of delta opioid peptides as nonaddicting analgesics.

Authors:  R S Rapaka; F Porreca
Journal:  Pharm Res       Date:  1991-01       Impact factor: 4.200

Review 2.  Mu opioids and their receptors: evolution of a concept.

Authors:  Gavril W Pasternak; Ying-Xian Pan
Journal:  Pharmacol Rev       Date:  2013-09-27       Impact factor: 25.468

Review 3.  Neural mechanisms of swallowing: neurophysiological and neurochemical studies on brain stem neurons in the solitary tract region.

Authors:  B J Sessle; J L Henry
Journal:  Dysphagia       Date:  1989       Impact factor: 3.438

4.  The untranslated region of (mu)-opioid receptor mRNA contributes to reduced opioid sensitivity in CXBK mice.

Authors:  K Ikeda; T Kobayashi; T Ichikawa; T Kumanishi; H Niki; R Yano
Journal:  J Neurosci       Date:  2001-02-15       Impact factor: 6.167

Review 5.  The genetics of pain and pain inhibition.

Authors:  J S Mogil; W F Sternberg; P Marek; B Sadowski; J K Belknap; J C Liebeskind
Journal:  Proc Natl Acad Sci U S A       Date:  1996-04-02       Impact factor: 11.205

6.  Immunomodulatory activity of mu- and kappa-selective opioid agonists.

Authors:  D D Taub; T K Eisenstein; E B Geller; M W Adler; T J Rogers
Journal:  Proc Natl Acad Sci U S A       Date:  1991-01-15       Impact factor: 11.205

7.  Fentanyl transdermal matrix patch (Durotep MT patch; Durogesic DTrans; Durogesic SMAT): in adults with cancer-related pain.

Authors:  Sheridan M Hoy; Gillian M Keating
Journal:  Drugs       Date:  2008       Impact factor: 9.546

8.  Opioid operant self-administration, analgesia, stimulation and respiratory depression in mu-deficient mice.

Authors:  G I Elmer; J O Pieper; S R Goldberg; F R George
Journal:  Psychopharmacology (Berl)       Date:  1995-01       Impact factor: 4.530

9.  Quantitative autoradiographic distribution of meptazinol-sensitive binding sites in rat brain.

Authors:  B A Adler; R R Goodman; G W Pasternak
Journal:  Cell Mol Neurobiol       Date:  1988-12       Impact factor: 5.046

Review 10.  Opioids and behavior: genetic aspects.

Authors:  H R Frischknecht; B Siegfried; P G Waser
Journal:  Experientia       Date:  1988-06-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.